Osteoporosis clinical trials

Other conditions

By location or age: Massachusetts

183 trials are recruiting, according to ClinicalTrials.gov.

Showing 100 of 183, newest first. Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Recruiting · Not applicable · Listed on Beacon

Synbiotic to Attenuate Resorption of the Skeleton

Ages 60 Years to no maximum · 1 site · Hebrew SeniorLife

Details and how to check if you qualify · NCT06389539 on ClinicalTrials.gov

Not yet recruiting · Phase 3

Fighting Osteoporosis With Risedronate Co-Therapy During Incretin

Ages 60 Years to no maximum · 1 site · Wake Forest University Health Sciences

NCT07943754 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

Ages 60 Years to no maximum · 9 sites · Sahlgrenska University Hospital

NCT07772609 on ClinicalTrials.gov

Recruiting · Not applicable

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Ages 18 Years to 100 Years · 1 site · Bettina Mittendorfer

NCT07083557 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Romosozumab and Denosumab Combination Therapy for Osteoporosis

Ages 45 Years to no maximum · 0 sites · Massachusetts General Hospital

NCT07909304 on ClinicalTrials.gov

Enrolling by invitation · Phase 3

Quanduzhong Capsules for Primary Osteoporosis

Ages 18 Years to 75 Years · 3 sites · Shanghai University of Traditional Chinese Medicine

NCT07895082 on ClinicalTrials.gov

Recruiting · Not applicable

Post-osteoporotic Fracture Exercise Program

Ages 18 Years to no maximum · 1 site · Western University, Canada

NCT07595991 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Exercise and Fall Prevention for Fracture Reduction

Ages 65 Years to no maximum · 1 site · Wolfgang Kemmler, PhD

NCT07897929 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass

Ages 45 Years to 80 Years · 0 sites · Transcenta Therapeutics (Hangzhou) Co., Ltd.

NCT07806331 on ClinicalTrials.gov

Recruiting · Not applicable

Bone Deterioration After Kidney Transplantation Assessed by DXA and HR-pQCT

Ages 18 Years to no maximum · 1 site · Medical University Innsbruck

NCT07935915 on ClinicalTrials.gov

Recruiting · Not applicable

Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis

Ages 45 Years to 70 Years · 1 site · Riphah International University

NCT07875894 on ClinicalTrials.gov

Recruiting · Not applicable

A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.

Ages 21 Years to 85 Years · 3 sites · Amber Implants B.V.

NCT07920484 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Osteoporosis & Renal Disease: Research in Primary Health Care Services

Ages 40 Years to 90 Years · 1 site · Universidade do Porto

NCT07848490 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an Inflatable Positioning Device: Technical Note and Retrospective Single-centre Case Series

Ages 18 Years to no maximum · 0 sites · Diakonie-Klinikum Stuttgart

NCT07847320 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 Years

Ages 18 Years to no maximum · 1 site · Tuen Mun Hospital

NCT07757373 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women

Ages 45 Years to 80 Years · 1 site · Associação Pan-Americana Multidisciplinar de Endocanabinologia

NCT07783295 on ClinicalTrials.gov

Not yet recruiting · Not applicable

EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL

Ages 50 Years to no maximum · 1 site · Alma Mater Europaea - Slovenia

NCT07763717 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Calcium-Rich Food Versus Calcium Carbonate for Bone Health

Ages 40 Years to 90 Years · 1 site · Cornell University

NCT07763509 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Effect of Postural Correction Exercises on Pelvic Floor Dysfunction in Postmenopausal Osteoporotic Women

Ages 55 Years to 65 Years · 1 site · Cairo University

NCT07806968 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)

Ages No minimum to no maximum · 1 site · AgNovos Healthcare, LLC

NCT07594639 on ClinicalTrials.gov

Recruiting · Phase 4

The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation

Ages 50 Years to 85 Years · 1 site · National Taiwan University Hospital

NCT07406685 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The Relationship Between Lipedema and Osteoporosis

Ages 18 Years to no maximum · 0 sites · Fatih Sultan Mehmet Training and Research Hospital

NCT07779603 on ClinicalTrials.gov

Recruiting · Phase 2

A Study of Romosozumab in People With Breast Cancer and Osteoporosis

Ages 18 Years to no maximum · 7 sites · Memorial Sloan Kettering Cancer Center

NCT07776613 on ClinicalTrials.gov

Not yet recruiting · Phase 1

Pharmacokinetics of Zoledronic Acid in Patients on Dialysis

Ages 18 Years to no maximum · 1 site · University of Campinas, Brazil

NCT07741136 on ClinicalTrials.gov

Not yet recruiting · Not applicable

High-Intensity Laser Therapy and Physiotherapy for Bone Health in Postmenopausal Women: A Randomized Trial

Ages 50 Years to 70 Years · 1 site · Iuliu Hatieganu University of Medicine and Pharmacy

NCT07734922 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Osteoporotic Fracture and Lidocaine Plaster 5% for Neuropathic Pain preventioN

Ages 50 Years to no maximum · 1 site · University Hospital, Clermont-Ferrand

NCT07691359 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Link Between ASCorbemia Level and Osteoporosis

Ages 50 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nice

NCT07660484 on ClinicalTrials.gov

Recruiting · Phase 1

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

Ages 45 Years to 70 Years · 1 site · University of Connecticut

NCT07365514 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF

Ages 18 Years to 80 Years · 1 site · Capital Medical University

NCT07645794 on ClinicalTrials.gov

Recruiting · Not applicable

REMS vs DXA for Osteoporosis Diagnosis and Fracture Risk Prediction

Ages 30 Years to 90 Years · 2 sites · BoneVue Diagnostics

NCT07876882 on ClinicalTrials.gov

Enrolling by invitation · Phase 2

The Effect of Osteoporotic Medications on Vertebral Bone Quality Score

Ages 50 Years to no maximum · 1 site · State University of New York at Buffalo

NCT07587775 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Osteoporosis and Sarcopenia Prevention in Middle-Aged Population

Ages 40 Years to 60 Years · 1 site · The University of Hong Kong

NCT07611097 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients

Ages 60 Years to no maximum · 1 site · Junbo Liang

NCT07639619 on ClinicalTrials.gov

Not yet recruiting · Not applicable

A Retrospective and Prospective Clinical Registry for Data Collection of Perimenopausal, Menopausal and Premature Ovarian Insufficiency Women

Ages 18 Years to 65 Years · 0 sites · IRCCS San Raffaele

NCT07606326 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Contribution of Bone to Urine Citrate

Ages 18 Years to no maximum · 1 site · University of Texas Southwestern Medical Center

NCT06811363 on ClinicalTrials.gov

Recruiting · Not applicable

Can Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women?

Ages 45 Years to no maximum · 1 site · Kanuni Sultan Suleyman Training and Research Hospital

NCT07677072 on ClinicalTrials.gov

Recruiting · Not applicable

People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

Ages 70 Years to no maximum · 1 site · McGill University Health Centre/Research Institute of the McGill University Health Centre

NCT07621679 on ClinicalTrials.gov

Recruiting · Not applicable

Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study

Ages 18 Years to no maximum · 1 site · Kanuni Sultan Suleyman Training and Research Hospital

NCT07677033 on ClinicalTrials.gov

Recruiting · Phase 2

A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

Ages 45 Years to 80 Years · 1 site · Shenzhen Salubris Pharmaceuticals Co., Ltd.

NCT07579936 on ClinicalTrials.gov

Recruiting · Not applicable

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

Ages 22 Years to no maximum · 3 sites · Precision IO Group

NCT07325578 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

OSTEOPOROSIS EDUCATION AND ITS IMPACT ON OSTEOPOROSIS HEALTH BELIEFS AND AWARENESS IN WOMEN AT RISK OF OSTEOPOROSIS

Ages 45 Years to 80 Years · 1 site · Bartın Unıversity

NCT07486076 on ClinicalTrials.gov

Recruiting · Not applicable

Comparing Implant Retention Versus Removal for MRONJ at Implant Sites

Ages 20 Years to no maximum · 1 site · Kyunghee University Dental Hospital

NCT07435259 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength

Ages 50 Years to 65 Years · 0 sites · Kanuni Sultan Suleyman Training and Research Hospital

NCT07519551 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Study in Patients With Osteoporosis and Fragility Fractures to Estimate the Extent and Impact of Delayed Administration of Anti-fracture Therapy

Ages 18 Years to no maximum · 1 site · Azienda Ospedaliero, Universitaria Pisana

NCT07512453 on ClinicalTrials.gov

Recruiting · Not applicable

Self-questionnaire in Osteoporosis

Ages 18 Years to no maximum · 1 site · CHU de Quebec-Universite Laval

NCT07067827 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Food Trial Evaluating Fecal Abundance of SBD111 With Once-Daily Versus Twice-Daily Administration in Healthy Adults

Ages 35 Years to no maximum · 0 sites · Solarea Bio, Inc

NCT07538167 on ClinicalTrials.gov

Recruiting · Not applicable

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Ages 50 Years to no maximum · 15 sites · AO Foundation, AO Spine

NCT07027306 on ClinicalTrials.gov

Recruiting · Not applicable

Artificial Intelligence-Guided Diagnosis for High-Risk Osteoporosis Populations: A Pragmatic Randomized Clinical Trial

Ages 40 Years to 80 Years · 3 sites · Taichung Veterans General Hospital

NCT07620834 on ClinicalTrials.gov

Recruiting · Not applicable

Radiographic Cortical Thickness of the Humerus in Detecting Post-Stroke Regional Bone Loss

Ages 18 Years to no maximum · 1 site · Istanbul Physical Medicine Rehabilitation Training and Research Hospital

NCT07651306 on ClinicalTrials.gov

Recruiting · Not applicable

A Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older

Ages 50 Years to no maximum · 3 sites · Promedius Inc

NCT07421713 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Female Osteoporosis

Ages 50 Years to 75 Years · 0 sites · Kayseri City Hospital

NCT07402772 on ClinicalTrials.gov

Recruiting · Not applicable

Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle Loss

Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Saint Etienne

NCT06541548 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes

Ages 50 Years to no maximum · 4 sites · Peking Union Medical College Hospital

NCT07063797 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)

Ages 50 Years to no maximum · 0 sites · Ufonia

NCT07464171 on ClinicalTrials.gov

Recruiting · Not applicable

Patient Education in Osteoporosis (RCT-PATOS)

Ages 50 Years to no maximum · 7 sites · University Hospital, Linkoeping

NCT07367776 on ClinicalTrials.gov

Recruiting · Not applicable

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

Ages 65 Years to no maximum · 2 sites · Brigham and Women's Hospital

NCT06731608 on ClinicalTrials.gov

Not yet recruiting · Not applicable

AGE Burden and Response to Antiresorptive Therapy in Osteoporosis

Ages 50 Years to no maximum · 0 sites · Bursa City Hospital

NCT07329543 on ClinicalTrials.gov

Recruiting · Not applicable

Effect of Biofeedback Activation on Balance in Osteoporotic Elderly

Ages 65 Years to 75 Years · 1 site · Mohamed Said Alsafy Alhamrawy

NCT07333989 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Bone Health in Postmenopausal Women: The Effect of Exercise With or Without Medication for Osteoporosis

Ages 55 Years to 75 Years · 1 site · Loughborough University

NCT07267325 on ClinicalTrials.gov

Recruiting · Phase 4

Step-down Therapy After Long-term Osteoporosis Treatment

Ages 50 Years to 85 Years · 1 site · National Taiwan University Hospital

NCT07281586 on ClinicalTrials.gov

Recruiting · Not applicable

Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders

Ages 18 Years to 90 Years · 1 site · Martin Blomberg Jensen

NCT07824102 on ClinicalTrials.gov

Recruiting · Not applicable

Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Questionnaires and REMS Densitometric Examination

Ages 30 Years to 45 Years · 1 site · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

NCT07508553 on ClinicalTrials.gov

Recruiting · Not applicable

Prunes Preventing Bone Loss in Perimenopause

Ages 44 Years to 55 Years · 1 site · Penn State University

NCT07120997 on ClinicalTrials.gov

Recruiting · Not applicable

Assessment and Comparison of Osteoporosis Risk Factors After Stroke

Ages 55 Years to 85 Years · 1 site · Ankara Etlik City Hospital

NCT07228611 on ClinicalTrials.gov

Recruiting · Not applicable

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

Ages 5 Years to 18 Years · 1 site · Meyer Children's Hospital IRCCS

NCT07412782 on ClinicalTrials.gov

Recruiting · Phase 4

Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis

Ages 50 Years to 80 Years · 1 site · National Taiwan University Hospital

NCT07283887 on ClinicalTrials.gov

Recruiting · Not applicable

The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients

Ages 40 Years to 65 Years · 1 site · Kirsehir Ahi Evran Universitesi

NCT07231822 on ClinicalTrials.gov

Recruiting · Not applicable

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

Ages 18 Years to 65 Years · 1 site · Istanbul Physical Medicine Rehabilitation Training and Research Hospital

NCT07253493 on ClinicalTrials.gov

Recruiting · Not applicable

Vitamin D Status and Multi-Omics Profiles in Primary Osteoporosis

Ages 18 Years to no maximum · 1 site · Dr. Li Chen

NCT07296471 on ClinicalTrials.gov

Recruiting · Not applicable

A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures

Ages 21 Years to 85 Years · 3 sites · Amber Implants B.V.

NCT07301749 on ClinicalTrials.gov

Recruiting · Not applicable

Chiropractor Delivered Virtual Intervention After Vertebral frActure

Ages 50 Years to no maximum · 1 site · University of Waterloo

NCT07288684 on ClinicalTrials.gov

Recruiting · Phase 2

Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

Ages 60 Years to 75 Years · 2 sites · Odense University Hospital

NCT07191353 on ClinicalTrials.gov

Enrolling by invitation · Phase 1

Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects

Ages 18 Years to 45 Years · 1 site · Shenzhen Salubris Pharmaceuticals Co., Ltd.

NCT07384104 on ClinicalTrials.gov

Recruiting · Not applicable

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Ages 18 Years to no maximum · 27 sites · Blueprint Medicines Corporation

NCT07143669 on ClinicalTrials.gov

Recruiting · Phase 4

GLP-1R Actions on Muscle and the Skeleton

Ages 18 Years to 50 Years · 1 site · Pennington Biomedical Research Center

NCT07154719 on ClinicalTrials.gov

Recruiting · Phase 4

StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis

Ages 18 Years to no maximum · 17 sites · University Hospital, Toulouse

NCT06767150 on ClinicalTrials.gov

Recruiting · Phase 2

COMPASS - COpenhagen MenoPAuSe Study

Ages 40 Years to 65 Years · 1 site · Martin Blomberg Jensen

NCT07254429 on ClinicalTrials.gov

Recruiting · Not applicable

Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis

Ages 35 Years to 70 Years · 2 sites · Regina Elena Cancer Institute

NCT07256769 on ClinicalTrials.gov

Not yet recruiting · Phase 4

The Effect of Semaglutide on Bone Health

Ages 50 Years to 75 Years · 1 site · The First Affiliated Hospital of Xiamen University

NCT07165158 on ClinicalTrials.gov

Recruiting · Not applicable

Resting-state Imaging and OSteoporosiS

Ages 50 Years to no maximum · 1 site · University Hospital, Clermont-Ferrand

NCT07030205 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Osteoporosis (DHEAL-COM-OP)

Ages 65 Years to no maximum · 1 site · Istituto Nazionale di Ricovero e Cura per Anziani

NCT06984380 on ClinicalTrials.gov

Recruiting · Not applicable

25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases

Ages 20 Years to 85 Years · 2 sites · Dionyssiotis, Yannis, M.D.

NCT06791044 on ClinicalTrials.gov

Recruiting · Not applicable

MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis

Ages 50 Years to no maximum · 2 sites · Istituto Auxologico Italiano

NCT07616401 on ClinicalTrials.gov

Recruiting · Not applicable

Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis

Ages 18 Years to no maximum · 1 site · Peter Humaidan

NCT07546552 on ClinicalTrials.gov

Not yet recruiting · Phase 1

A Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches

Ages 18 Years to 70 Years · 1 site · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

NCT07085520 on ClinicalTrials.gov

Recruiting · Not applicable

Health Literacy and Osteoporosis Awareness

Ages 65 Years to no maximum · 1 site · Bandırma Onyedi Eylül University

NCT07419451 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge

Ages 50 Years to no maximum · 0 sites · SingHealth Polyclinics

NCT07034131 on ClinicalTrials.gov

Recruiting · Phase 3

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Ages 50 Years to 85 Years · 1 site · Qilu Pharmaceutical Co., Ltd.

NCT07062978 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60

Ages 50 Years to 59 Years · 0 sites · Beylikduzu State Hospital

NCT07045012 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The Oswestry Metabolic BONE Cohort

Ages 18 Years to no maximum · 1 site · Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

NCT07014306 on ClinicalTrials.gov

Not yet recruiting · Phase 3

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

Ages 50 Years to 85 Years · 0 sites · Qilu Pharmaceutical Co., Ltd.

NCT06898060 on ClinicalTrials.gov

Recruiting · Not applicable

Dairy vs Plant-based Beverages for Improving Bone Health During Exercise

Ages No minimum to no maximum · 1 site · University of Saskatchewan

NCT06946316 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis

Ages 60 Years to 70 Years · 0 sites · Peking University Third Hospital

NCT06951776 on ClinicalTrials.gov

Recruiting · Not applicable

Orthorexia Nervosa in Postmenopausal Osteoporosis

Ages 55 Years to 75 Years · 1 site · Beylikduzu State Hospital

NCT06947213 on ClinicalTrials.gov

Recruiting · Phase 4

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

Ages 50 Years to 90 Years · 1 site · National Taiwan University Hospital

NCT06938152 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.

Ages 50 Years to no maximum · 1 site · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

NCT07120854 on ClinicalTrials.gov

Recruiting · Not applicable

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

Ages 20 Years to 70 Years · 1 site · Grigore T. Popa University of Medicine and Pharmacy

NCT07141043 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Holistic Integration for Healthy Longevity and Aging in Place

Ages 55 Years to no maximum · 0 sites · National Taiwan University Hospital

NCT06882434 on ClinicalTrials.gov

Recruiting · Not applicable

A Study of Amorphous Calcium Carbonate in Postmenopausal Women

Ages 60 Years to 90 Years · 1 site · Universal Integrated Corp.

NCT06728462 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Periprosthetic Plate Over Humeral Nail

Ages 16 Years to 40 Years · 0 sites · Assiut University

NCT06812195 on ClinicalTrials.gov

More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Rett syndrome clinical trials